Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 3;62(4):1426-1435.
doi: 10.1093/rheumatology/keac481.

Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis

Affiliations
Review

Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis

Andrés González García et al. Rheumatology (Oxford). .

Abstract

Idiopathic multicentric Castleman disease (iMCD) is an infrequent and life-threatening disorder characterized by systemic inflammatory symptoms, generalized lymphadenopathy, polyclonal lymphocyte proliferation and organ dysfunction caused by a hyperinflammatory state. It accounts for one-third to one-half of all multicentric Castleman disease (MCD) cases. iMCD is often associated with autoimmune manifestations that may precede the iMCD diagnosis, be identified at the same time or follow it. In addition, iMCD may also coincide with a number of autoimmune diseases (such as psoriasis or myasthenia gravis) or autoinflammatory diseases (such as familial Mediterranean fever). Moreover, diverse inflammatory disorders, such as rheumatoid arthritis, systemic lupus erythematosus, adult-onset Still disease, systemic juvenile idiopathic arthritis, immunoglobulin (IgG4) related disease, or the recently described VEXAS syndrome, can present clinical features or lymphadenopathy with histopathological 'Castleman-like' findings compatible with those of iMCD. Given the iMCD clinical heterogeneity and the overlap with other autoimmune or autoinflammatory disorders, iMCD diagnosis can be challenging. In this review, we explore the overlap between iMCD and inflammatory diseases and provide practical guidance on iMCD diagnosis in order to avoid misdiagnosis and confusion with other autoimmune or autoinflammatory conditions.

Keywords: IL-6; autoimmune diseases; cytokine storm; diagnosis; differential; multi-centric Castleman disease.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Castleman disease classification. CD: Castleman disease; HHV-8: human herpesvirus-8; HIV: human immunodeficiency virus; iMCD: idiopathic multicentric Castleman disease; MCD: multicentric Castleman disease; NOS: not otherwise specified; POEMS: polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder and skin changes; TAFRO: thrombocytopenia, anasarca, reticulin fibrosis, renal dysfunction and organomegaly

References

    1. Fajgenbaum DC, Uldrick TS, Bagg A. et al. International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood 2017;129:1646–57. - PMC - PubMed
    1. Zhou T, Wang HW, Pittaluga S, Jaffe ES.. Multicentric Castleman disease and the evolution of the concept. Pathologica 2021;113:339–53. - PMC - PubMed
    1. Sun DP, Chen WM, Wang L. et al. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases. J Cancer Res Clin Oncol 2021;147:2107–15. - PMC - PubMed
    1. Muskardin TW, Peterson BA, Molitor JA.. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol 2012;24:76–83. - PubMed
    1. Endo Y, Koga T, Otaki H. et al. Idiopathic multicentric Castleman disease with novel heterozygous Ile729Met mutation in exon 10 of familial Mediterranean fever gene. Rheumatol 2021;60:445–50. - PubMed

Publication types

Supplementary concepts